Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received February 24, 2017
- Revision received June 23, 2017
- Accepted September 1, 2017
- Published first September 14, 2017.
Article Versions
- Previous version (September 14, 2017 - 07:33).
- You are currently viewing a Previous version of this article (September 25, 2017 - 06:29).
- View the most recent version of this article
Copyright & Usage
©2017 American Association for Cancer Research.
Author Information
- Matthew J. Atherton1,
- Kyle B. Stephenson2,
- Jonathan Pol1,
- Fuan Wang1,
- Charles Lefebvre3,
- David F. Stojdl2,3,
- Jake K. Nikota2,
- Anna Dvorkin-Gheva1,
- Andrew Nguyen1,
- Lan Chen1,
- Stephanie Johnson-Obaseki4,
- Patrick J. Villeneuve5,
- Jean-Simon Diallo6,
- Jim Dimitroulakos6,
- Yonghong Wan1, and
- Brian D. Lichty1,2,*
- 1McMaster Immunology Research Centre, Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Canada.
- 2Turnstone Biologics, Ottawa, Canada.
- 3Stojdl Lab, CHEO Research Institute, Children's Hospital of Eastern Ontario, Ottawa, Canada.
- 4Department of Otolaryngology-Head and Neck Surgery, The Ottawa Hospital, Ottawa, Canada.
- 5Department of Surgery, The Ottawa Hospital, Ottawa, Canada.
- 6Centre for Cancer Therapeutics, The Ottawa Hospital Research Institute, and Faculty of Medicine and the Department of Biochemistry at the University of Ottawa, Ottawa, Canada.
- ↵*Corresponding Author:
Brian D. Lichty, McMaster University 1200 Main Street West MDCL 5023, Hamilton, Ontario L8N 3Z5, Canada. Phone: 905-521-2100; Fax: 905-525-6750; E-mail: lichtyb{at}mcmaster.ca
Published OnlineFirst September 25, 2017
doi: 10.1158/2326-6066.CIR-17-0102
Customized Viral Immunotherapy for HPV-Associated Cancer
Jump to section
Advertisement